Citadel Advisors has reported a short position of 0.53 percent of the capital in Danish pharmaceutical company Zealand Pharma. The previous position was 0.48 percent.
Citadel Advisors thus has a public short position in the company.
Citadel Advisors has reported a short position of 0.53 percent of the capital in Danish pharmaceutical company Zealand Pharma. The previous position was 0.48 percent.
Citadel Advisors thus has a public short position in the company.
Follow us
Finwire AB
Järntorget 3
SE-413 04 Göteborg
Vasagatan 52
SE-111 20 Stockholm
newsroom@finwire.com
+46 (0)738 50 35 45
sales@finwire.com
+46 (0)704 25 58 20
media@finwire.com
+46 (0)709 78 77 65
Finwire® is a registered trademark. © 2020-2026 Finwire AB
